Literature DB >> 14649104

Depression and anxiety in hypothyroidism.

M M Demet1, B Ozmen, A Deveci, S Boyvada, H Adiguzel, O Aydemir.   

Abstract

The aim of the study was to determine the prevalence and severity of depression and anxiety in patients with hypothyroidism and to compare this with euthyroid patients. Thirty patients with hypothyroidism and 30 euthyroid controls attending the Endocrinology outpatient department of Celal Bayar University, Medical Faculty were included in the study. The hormonal screening was done by immunoassay and haemagglutination methods. Then, for psychiatric assessment, Hospital Anxiety and Depression Scale (HAD), Hamilton Depression Rating Scale (HAM-D), and Hamilton Anxiety Rating Scale (HAM-A) were used. There was no difference between the two groups in terms of demographic features. Total scores obtained from the scales used in the study did not differ significantly (p > 0.05). The frequency of items of both HAM-D and HAM-A did not show any differences in the two groups. By Wilks' Lambda discriminant analysis, depressive mood (HAM-D#1) was found to be the discriminating feature between the hypothyroid group and the euthyroid group. Therefore, depression and anxiety were not outstanding features in hypothyrodism. However, depression was more significant in the hypothyroid than euthyroid group.

Entities:  

Mesh:

Year:  2003        PMID: 14649104

Source DB:  PubMed          Journal:  West Indian Med J        ISSN: 0043-3144            Impact factor:   0.171


  2 in total

1.  Impact of long-term benzodiazepine use on cognitive functioning in young adults: the VISAT cohort.

Authors:  Olivia Boeuf-Cazou; Bienvenu Bongue; David Ansiau; Jean-Claude Marquié; Maryse Lapeyre-Mestre
Journal:  Eur J Clin Pharmacol       Date:  2011-04-15       Impact factor: 2.953

Review 2.  Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder.

Authors:  Juan Joseph Young; Tim Silber; Davide Bruno; Isaac Robert Galatzer-Levy; Nunzio Pomara; Charles Raymond Marmar
Journal:  Front Psychiatry       Date:  2016-04-25       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.